Opus Genetics, Inc.(IRD)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Opus Genetics, Inc. (IRD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores IRD at 13.4/100 on a 32-signal composite quality model, placing it at rank #2,875 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Opus Genetics, Inc. reports quarterly revenue of $755.0K, net income of $-8.1M. Top institutional holders of IRD by reported 13-F value include Caligan Partners, ADAGE CAPITAL PARTNERS GP, L.L.C., BIOS Capital Management, based on the most recent SEC filings. IRD trades on the Nasdaq exchange and files with the SEC under CIK 1228627. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IRD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Opus Genetics, Inc. directly from SEC EDGAR.

AI Quality Score

13.4/100

AI Rank

#2,875

Revenue

$755.0K

Net Income

$-8.1M

IRD key financials by period

Opus Genetics, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$14.2M$-49.6M—
FY 202410-K$11.0M$-57.5M—
FY 202310-K$19.0M$-10.0M-55.5%
FY 202210-K$39.9M$17.9M45.7%
FY 202110-K$589.0K$-56.7M—
FY 201910-K$3.0M$-6.2M-139.8%

Institutions holding IRD

Institutional investors reporting a position in Opus Genetics, Inc. on SEC Form 13F.
InstitutionSharesValueReported
Caligan Partners6,077,084$25.0M2026-06-30
ADAGE CAPITAL PARTNERS GP, L.L.C.6,029,775$24.8M2026-06-30
BIOS Capital Management3,683,429$15.1M2026-06-30
BlackRock3,116,487$12.8M2026-06-30
BALYASNY ASSET MANAGEMENT L.P.3,087,866$12.7M2026-06-30
Nantahala Capital Management3,061,359$12.6M2026-06-30
VANGUARD CAPITAL MANAGEMENT2,958,683$12.2M2026-06-30
Boxer Capital Management2,815,000$11.6M2026-06-30
Trails Edge Capital Partners2,743,658$11.3M2026-06-30
MILLENNIUM MANAGEMENT2,302,101$9.5M2026-06-30
SEC EDGAR: CIK 1228627 →
IRD

Opus Genetics, Inc.

IRD
NasdaqSmall CapHealthcare

13F Pro Quality Score

13.4/100

Rank #2,875 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$755.0K

Net Income

Q2 2026
EDGAR

$-8.10M

EPS (Diluted)

Q2 2026
EDGAR

$-0.14

Top Institutional Holders

as of Q2 2026
$236.52M total
Caligan Partners LP
$24.98M0.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.
$24.78M0.0%
BIOS Capital Management, LP
$15.14M0.0%
BlackRock, Inc.
$12.81M+2009.4%
BALYASNY ASSET MANAGEMENT L.P.
$12.69M+13.6%
Nantahala Capital Management, LLC
$12.58M+82.1%
VANGUARD CAPITAL MANAGEMENT LLC
$12.16M+20.8%
Boxer Capital Management, LLC
$11.57M+25.1%
Trails Edge Capital Partners, LP
$11.28M+448.7%
MILLENNIUM MANAGEMENT LLC
$9.46M-12.5%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…